Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker-Reference-Cited by-同舟云学术

Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker

Published:2024-07-29 Issue:1 Volume:22 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Jiang Wen,Chen Lan,Li Rongrong,Li Jiang,Dou Shengjin,Ye Lulu,He Yining,Tian Zhen,Yao Yanli,Zhu Guopei

Funder

Innovative Research Team of High-level Local Universities in Shanghai

Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences

Shanghai Clinical Research Center for Oral Diseases

Project of Shanghai Municipal Health Commission

Beijing Xisike Clinical Oncology Research Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12916-024-03541-6.pdf

Reference45 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33:3269–76.

3. Divi V, Chen MM, Nussenbaum B, Rhoads KF, Sirjani DB, Holsinger FC, et al. Lymph node count from neck dissection predicts mortality in head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34:3892–7.

4. Daly ME, Le Q-T, Kozak MM, Maxim PG, Murphy JD, Hsu A, et al. Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control. Int J Radiat Oncol. 2011;80:1412–22.

5. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre J-L, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.